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(DOPS/DOPC,40160 mol/mol) Kd= 3 x 10-11 M. When
the mole percentage of DOPS in the phospholipid vesicles is
lowered from 20 to 5 mol Vo,Ihere is a gradual increase of the
K6. In the presence of l0 pM phospholipid vesicles containing
5 mol Vo DOPS and 95 mol % DOPC Ka = 2.8 X 10-10 M.
The K6 measured in the presence of phospholipid vesicles
containing 5 mol Vo DOPS and 95 mol Vo DOPC is inde-
pendent of the phospholipid concentration. Two models are
discussed that can quantitatively explain the effect of phos-
pholipid vesicles on the complex formation between factor Xa
and factor Va. Studies on the effect of the polypeptides with
.r}1,80000 and M,94000 of which factor Va is composed on
the K6 of the factor Xa-Ya complex suggest that factor Xa
binding to factor Va requires a Ca2+-mediated interaction
between the two polypeptides.
prothrombin interact at increased local concentrations and
factor Va changes the catalytic capacity of factor Xa.
Another important function of factor Va in haemostasis was
discovered by Miletich et al. (1978). Their experiments
suggest that factor Va is part of a highly specific factor Xa
binding site on human blood platelets. The same tight binding
site for factor Xa is also present at the surface of bovine blood
platelets (Dahlbiick & Stenflo, 1978). Recently, Tracy et al.
(1981) demonstrated that factor Xa and factor Va interact
stoichiometrically at the platelet surface and that factor Xa
binds to platelet-bound factor Va with an apparent dissociation
constant of 6 x 10-10 M. Similar binding parameters were
obtained in a phospholipid model system (Nesheim et al.,
1979b).
The precise mode of action of phospholipid in promoting
the interaction between factor Xa and factor Va is not known.
In fact, it is not unequivocally demonstrated that factor Xa-Va
complex formation at the platelet surface is the result of
protein-phospholipid interaction per se. While Bevers et al.
I The nomenclature of the blood coagulation factors used is that
recommended by the Task Force on Nomenclature of Blood Clotting
Zymogens and Zymogen Intermediates.
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ABSTRAcT: The interaction between factor Xa and factor Va
was investigated both in solution and in the presence of
phospholipid vesicles with varying contents of phosphatidyl-
serine. The binding parameters were inferred from the kinetics
of prothrombin activation. Factor Xa and factor Va form in
solution an equimolar complex with a dissociation constant
of 3.3 x 104 M. Phospholipid vesicles promote the formation
of the factor Xa-Va complex. The Ka of complex formation
is dependent on both the phospholipid concentration and the
composition of the phospholipid vesicle. For the interaction
between factor Xa and factor Va in the prosence of phos-
pholipid vesicles containing 40 mol 7o dioleoylphosphatidyl-
serine (DOPS) and 60 mol 7o dioleoylphosphatidylcholine
(DOPC), the K6 increases linearly with increasing phospholipid
concentration. In the presence of l0 pM phospholipid
rT't
Ihe activation of blood coagulation factor II (prothrombin)r
into thrombin, catalyzed by the serine protease factor Xa,
requires at physiological conditions the presence of the non-
enzymatic components phospholipid, Ca2+ ions, and factor Va.
It has been shown that these so-called accessory components
augment the rate of prothrombin activation and that a pro-
thrombinase complex composed of factor Xa, negatively
charged phospholipid, Ca2+, and factor Va is the most efficient
in catalyzing prothrombin activation (Suttie & Jackson, 1977).
Kinetic studies on prothrombin activation by prothrombinase
complexes of different composition (factor Xa in either the
absence or presence ofphospholipid, Ca2+, andfor factor Va)
reveal that phospholipids cause a profound decrease of the K-
for prothrombin, while factor Va causes a drastic increase of
lhe V^"" of thrombin formation (Rosing et al., 1980). The
changes of the kinetic parameter$ caused by the accessory
components are consistent with a model in which phospholipid
provides a surface upon which factor Xa, factor Va, and
r From the Department of Biochemistry, Biomedical Center, Rijksu-
niversiteit Limburg, Maastricht, The Netherlands. Receiued March 12,
1982. P.v.d.W. was supported by the Netherlands Organization for the
Advancement of Pure Scientific Research (Z.W.O.).
0006-2960/82 1042r-s494$01.25l0 @
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(1982) reported that triggering ofplatelets with collagen plus
thrombin results in the exposure of phosphatidylserine mole-
cules at the platelet outer surface with a concomitant increase
in prothrombinase activity, Kane et al. (1980) and Tracy et
al. (1981) observed that platelet activation is not required for
the interaction of factor Xa with factor Va at the platelet
surface.
The purpose of the experiments described in this paper is
to assess the contribution of protein-protein and protein-
phospholipid interactions to the specificity and high affinity
of the binding of factor Xa to phospholipid-bound factor Va.
Therefore, we studied the interaction of factor Xa with factor
Va in the absence and in the presence of phospholipid vesicles
with a varying content of phosphatidylserine. In a first attempt
to reveal the structural requirements of the factor Va molecule
for binding factor Xa, we also studied the interaction between
factor Xa and isolated subunits with molecular weights of
80 000 and 94 000 of which factor Va is composed (Esmon,
1979).
Materials and Methods
S 22382 was purchased from AB Kabi Diagnostica. Ben-
zamidine and DFP were obtained from Sigma. All reagents
used were of the highest grade commercially available.
Proteiru. Bovine factors X1 and X2 were prepared according
to Fujikawa et al. (1972a). RVV-X was purified from the
crude venom as described by Schiffman et al. (1969). Bovine
factor Xa was prepared from bovine factor Xt with RVV-X
according to the method of Fujikawa et al. (1972b).
Bovine prothrombin and thrombin were purified as described
earlier (Rosing et al., 1980). Prethrombin I was purified
according to the method of Owen et al. (1914). Decarboxy-
prothrombin was a kind gift of Dr. Vermeer.
Bovine factor V was purified by a modification of the me-
thod of Esmon (1979). Bovine blood was obtained by veni-
puncture ofcows treated with phenprocoumon (average levels
of the factors II and X were 2OVo and 5Vo, respectively). The
blood was collected in l-L plastic bottles containing 100 mL
of 100 mM sodium oxalate. 100 mM benzamidine. 20000
units of heparin, and 0.2 mglmL of soybean trypsin inhibitor.
Plasma (12 L) was obtained by centrifugation of the blood
at 4 "C for 25 min at 2500 rpm in a MSE Mistral-6l cen-
trifuge. BaSOa (50 mg/ml-) was added to the plasma, and
the suspension was stirred for 15 min at 4 "C. The plasma
supernatant after BaSOa adsorption was adsorbed to QAE-
Sephadex (l L of swollen gel equilibrated in l0 mM Tris-
HCI-100 mM NaCl, pH 7.5) for 30 min under gentle stirring.
The QAE-Sephadex was filtered on a funnel overlaid with
nylon cloth, washed with l0 L of the equilibration buffer,
resuspended in a buffer containing l0 mM Tris-HCl, 100 mM
NaCl, and 20Vo (vlv) glycerol, pH 7.5, and packed into a
column (10 x 30 cm). Factor V was eluted with l0 mM
Tris-HCl, 500 mM NaCl, and l0 mM benzamidine, pH 7.5.
The eluate was dialyzed against l0 mM Tris-HCl, 100 mM
NaCl, 10 mM benzamidine, and 20Vo (v/v) glycerol, pH 7.5,
and applied to a DEAE-Sephadex column (5 x 30 cm)
equilibrated with the dialysis buffer. The column was de-
2 Abbreviations: S 2238, o-Phe-l-Pip-r-Arg-p-nitroanilide; S 2222,
N-benzoyl-t--Ile-l-Glu-[Y-Or]-Gly-r-Arg-p-nitroanilide; DFP, diiso-
propyl fluorophosphate; RVV-X, purified factor X activator from Rus-
sel's viper venom; LC, light chain; HC, heavy chain; DOPS, 1,2-
dioleoyl-sn-glycero-3-phosphoserine; DOPC, 1,2-dioleoyl-sn-glycero-3-
phosphocholine; Tris, tris(hydroxymethyl)aminomethane; EDTA, eth-
ylenediaminetetraacetic acid; NaDodSOa, sodium dodecyl sulfate; QAE,
[diethyl(2-hydroxypropyl)amino]ethyl; DEAE, diethylaminoethyl; SP,
sulfopropyl.
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veloped at 4 "C with a linear gradient from 100 mM NaCl
in 20 mM Tris-HCl, l0 mM benzamidine, and 20Vo (vlv)
glycerol, pH 7.5, to 300 mM NaCl in 20 mM Tris-HCl-lO0
mM benzamidine, pH 7.5 (3.0 L/reservoir). Factor V activity
eluted at 200-250 mM NaCl. The factor V containing
fractions were diluted with an equal volume (normally I L)
of a buffer containing 20 mM potassium phosphate, 20 mM
Tris-HCl, 150 mM sodium oxalate, and l0 mM benzamidine,
pH 7.0. Calcium chloride (2 M) was added slowly with
stirring to a final concentration of 100 mM. This mixture was
stirred for 30 min at 4 "C. The calcium oxalate and calcium
phosphate precipitate was collected by centrifugation for 20
min at 20009. Factor V activity was eluted with 2 times 250
mL of 200 mM potassium phosphate, 10 mM benzamidine,
and 2 mM DFP, pH 7.0. The eluate was saturated to 30Vo
with ammonium sulfate, stirred for 30 min at 4 oC, and then
centrifuged for 20 min at 20009. Factor V precipitated when
the supernatant was saturateA to 60Vo with ammonium sulfate.
The precipitate was spun down and resuspended in a minimal
volume of 20 mM Tris-HCl, 10 mM benzamidine, and I mM
DFP, pH 7.5, and applied to a column (5 x 100 cm) of Ul-
trogel AcA 22 equilibrated in 50 mM Tris-HCl, 400 mM
NaCl, and l0 mM benzamidine, pH 7.5. Factor V appeared
after about 700 mL of eluate. The fractions of highest specific
activity were pooled and stored at -80 oC.
Bovine factor Va (unfractionated factor Va) was obtained
by incubating 0.3 mg/ml factor V with thrombin (0.2 pS/mL)
in 50 mM Tris-HCl, 100 mM NaCl, and 2 mM CaCl2, pH
7.5. at 37 oC for 30 min. The activation of factor V was
followed by assay of factor Va activity and by polyacrylamide
gel electrophoresis in the presence of sodium dodecyl sulfate.
After complete activation, the factor Va solution was diluted
in 50 mM Tris-HCl, 100 mM NaCl, 2 mM CaCl2, and 0.5
mglmL ovalbumin, pH 7.5, l:50, and stored at -80 oC.
Factor Va was stable for at least 6 months.
The factor Va subunits with molecular weights of 80 000
(factor Va LC) and 94 000 (factor Va HC) were isolated by
a modification of the method of Esmon (1979). Factor Va
(30 mg) in 20 mM Tris-HCl, 50 mM NaCl, and 2 mM
EDTA, pH 7.5, was applied to a SP-Sephadex column (1.5
x 30 cm) coupled to a QAE-Sephadex column (1.5 x 30 cm),
both equilibrated with 20 mM Tris,50 mM NaCl, and 2 mM
EDTA, pH7.5. Subsequently, the SP-Sephadex and QAE-
Sephadex columns were developed separately with linear
gradients from 50 mM NaCl to 200 mM NaCl and from 50
mM NaCl to 500 mM NaCl (150 ml/reservoir), respectively.
The factor Va LC was eluted from the SP-Sephadex column
(100 mM NaCl), and the factor Va HC was eluted from the
QAE-Sephadex column (350 mM NaCl).
Phospholipid Vesicle Preparations. Phospholipid vesicles
were made from a mixture of 1,2-dioleoyl-sn-glycero-3-
phosphoserine and 1,2-dioleoyl-sn-glycero-3-phosphocholine
in a buffer containing 50 mM Tris-HCl-I00 mM NaCl, pH
7.5, as described earlier (Rosing et al., 1980).
Reconstitution of Factor Ya from lts Subunits (Factor Va
LC and Factor Ya HQ. Factor Va LC (0.3 mg/ml) in 50
mM Tris-HCl, 100 mM NaCl,20 mM CaCl2, and 0.5 mg/ml
ovalbumin, pH 7.5, and factor Va HC (0.4 mg/ml.) in the
same buffer were incubated at 37 "C. The time course of
factor Va activity was followed by a factor V assay.
Factor V Assay. Factor V was assayed in a one-stage assay
utilizing purified bovine coagulation factors. A sample (50
s.L) was incubated with 50 pL of factor Xa (0.1 nM), 50 pL
of a mixture containing phospholipid (100 pM) and human
fibrinogen (4 mg/ml.), and 50 p,L of 25 mM CaCl2 for 30 s
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at 37 "C. The assay was initiated by the addition of 50 pL
of prothrombin (5 pM). The time required for clot formation
was measured. Samples were diluted in 50 mM Tris-HCl, 100
mM NaCl, and 2 mM CaCl2, pH 7.5, containing ovalbumin
(0.5 mg/ml-). The purified coagulation factors were in the
same buffer. Pooled bovine oxalated plasma was used for the
construction of standard curves. The assay had a functional
range from 0.05 to l0 milliunits/ml (clotting times from 300
to 60 s). One unit of factor V was defined as the amount
present in I mL of bovine Plasma.
Protein Concentration.r. Factor Xa concentrations were
determined by active site titration with p-nitrophenyl p-
guanidinobenzoate hydrochloride according to Smith ( 1973).
The molar concentrations of the other proteins were calculated
from the following molecular weights and E|ft;1ff: pro-
thrombin 72000,15.5 (Owen et al.,1974); prethrombin 1
50200, 19.2 (Owen et al, 1974); factor V 330000' 9.6
(Nesheim et al.,1979a); factor Va LC 80000, 15.8; factor Va
HC 94000, 9.6 (Bsmon, 1979).
Measurement of Rates of Prothrombin Actiuation. To
determine the K6 and the stoichiometry of complex formation
between factor Xa and factor Va, we used a method in which
initial rates of prothrombin activation are a measure for the
amount of factor Xa-Va complex present in a reaction mixture
(for a description of this method, see below) ' Rates of pro-
thrombin activation were calculated from the amounts of
thrombin determined after different time intervals with the
synthetic chromogenic subrstrate S 2238 as described previously
(Rosing et al., 1980). The conversion of S 2238 by thrombin
was followed by measuring the absorbance change on an
Aminco DW-2 spectrophotometer operating in the dual-
wavelength mode (tr*onor = 405 nm and tr-ono2 = 500 nm)'
Method To Determine Binding Interaction between Factor
Xa and Factor Va from Kinetic Measurements. Kinetic
studies on prothrombin activation (Nesheim et al., 1979b)
show that in the presence of factor Va, prothrombin activation
is catalyzed by an equimolar complex between factor Xa and
factor Va. The initial assumption in this study is that the
formation of the complex is described by
factor Xa * factor Va + factor Xa-Va (l)
The dissociation constant of the factor Xa-Va complex is
Ko = [factor Va]6""[factor Xafyn/lfactor Xa-Va] (2)
When a fixed amount of factor Xa is titrated with factor Va
[factor Xa]r,* = [factor Xa]o 
- [factor Xa-Va] (3)
in which [factor Xa]e is the total concentration of factor Xa
present. Substituting eq 3 into eq 2 gives
K6 = [factor Va]1,""([factor Xa]s 
-
[factor Xa-Ya\) /lfactor Xa-Va] (4)
which can be rearranged into
| /lfactor Xa-Val =
(l / lfactor Valr,*XKo/ [factor Xa]s) * I / [factor Xa]q
(5)
When prothrombin is added to a reaction mixture in which
factor Xa, factor Va, and the factor Xa-Va complex are in
equilibrium, conditions can be chosen such that the rate of
prothrombin activation is proportional to the amount of factor
Xa-Va complex present, since noncomplexed factor Xa cat-
alyzes prothrombin activation at a rate negligible to that of
the factor Xa-Va complex (Rosing et al., 1980). In that case,
the rate of prothrombin activation is
O  1  6 1 5 2 2 3 0 4 . |  6 5  0  1  6 1 5  2 2 3 0 4 1  6 5  m i n .
0.1 0.3 20 4.2 6.6 70 7,0 6.9 0.1 03 2'042 66 7.0 7.0 69 u,/ml x t0-'
ntcune 1: Activation time course of factor V by thrombin. Factor
V (0.5 mg/ml) was incubated with thrombin (O.l pglmL) at 37 oC
in 0.05 M'Tris-HCl-0.1 M NaCl, pH 7.5. Samples were removed
from the reaction mixture at the times given below the gels and assayed
for factor V activity. At the same time intervals aliquots (50 pL)
of the incubation mixture were added to 50 pL of 2% sodium dodecyl
sulfate, l07o (v/v) mercaptoethanol, and 50 mM EDTA, pH 7.8.{4
kept for Z mii at 100 oe. Samples were electrophoresed on 7.57o
NiDodsor-acrylamide gels and stained with Coomassie blue (A)
and with periodic acid-Schiffs reagent (B).
in which c is a constant determined by the concentration of
prothrombin present and the kinetic parameters of pro-
thrombin activation by the factor Xa-Va complex. When all
factor Xa present is complexed with factor Va, [factor Xa-Va]
= [factor Xa]s, and the maximal rate of prothrombin acti-
vation is equal to
V^r" = c[factor Xa]6 Q)
Substituting eq 6 and 7 into eq 5 gives
| /u = (l /[factor Va]s.*)(Ka/V**) + | /V^," (8)
When [factor Xa]o (( K6, the amount of factor Va required
for saturating factor Xa is in large excess over [factor Xa]6,
and [factor Va]6* = [factor Va]e, where [factor Va]s is the
total concentration of factor Va present. So
| /u = (l /lfactor Vals)(rK6 /V**) + | /Vna* (9)
An equation similar to 9 can be derived when a fixed amount
of factor Va is titrated with factor Xa
| /u = (l /lfactor Xale)(K4 /V^^^) + | /Vn ^ (10)
A plot of l/u vs. either 1/[factor Va]6 or 1/[factor Xa]e is
linear with an intercept at the ordinate equal to I f V^u, and
at the abscissa equal to -l lKd. K6 and V*"were determined
by statistical analysis of the data as described by Eisenthal
& Cornish-Bowden (1974).
Results
Comments on Purification of Factor V and Isolation of End
Products of Thrombin-Catalyzed Actioation of Factor V.
Factor V prepared by a modification of the method of Esmon
(1979) as described under Materials and Methods is a sin-
gle-chain polypeptide with an apparent M, of 350000 as de-
termined with NaDodSOa electrophoresis (Figure l). In
contrast to Esmon (1979) we did not observe a tightly spaced
doublet. The absence ofthe doublet in our preparations is due
to the different way in which we obtained the blood as starting
material (i.e., venipunction of cows treated with phenpro-
coumen vs. slaughterhouse blood). We have purified factor
V approximately 2000-fold [sp act. 24 units ml-_r (absorbance
unit at 280 nm)-11 with a 20Vo yield.
The factor V preparation appears to be free of phospholipid
contamination. Phospholipid as estimated by organic phos-
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phate measurement according to the method of B0ttcher et
al. (1961) was undetectable in a sample containing 2 mg of
factor V (less than 0.5 mol of phospholipid/mol of factor V).
In addition, incubation of factor Va (l pmol/L) with phos-
pholipase A2 from Naja naja (2IU lmL) in the presence of
l0 mM CaCl2 for 30 min at37 "C did not result in a change
in factor Va activity as measured in the absence of phospho-
lipid under the conditions as described in the legend to Figure
2A. When incubated with thrombin, our factor V preparations
are activated 75-100-fold. The lower increase in specific
activity reported by Esmon (1979),10-16-fold, can be ac-
counted for by the different factor V assays used. Analysis
of the fully activated factor V by NaDodSOa gel electropho-
resis and staining of the gels with periodic acid-Schiffs reagent
(PAS) and Coomassie blue reveal that activation of factor V
by thrombin gives rise to four polypeptides with M, 150 000,
94000,80000, and 65000 (Figure l). The polypeptides with
M. 150000 and 65000 could only be detected by PAS staining.
The four polypeptides were isolated by ion-exchange chro-
matography as described under Materials and Methods. The
polypeptide with M,80000 eluted from the SP-Sephadex
column (0.10 M NaCl). The polypeptides with M, 65 000,
94000, and 150000 eluted from the QAE-Sephadex at 0.15,
0.35, and 0.40 M NaCl, respectively. No factor Va activity
could be detected in any of the column fractions. As reported
by Esmon (1979), factor Va activity could be restored by
mixing the SP-Sephadex fraction that contains the polypeptide
with M,80000 (factor Va LC) with the QAE-Sephadex
fraction containing the polypeptidewith M,94000 (factor Va
HC) in the presence of 20 mM CaCl2. Therefore, we consider
the polypeptides with M,65000 and 150000 as activation
peptides.
Binding Interaction between Factor Xa and Factor Ya in
Solution Inferred from Kinetics of Prothrombin Actiuation.
The dissociation constant (&) of the factor Xa-Va complex
was determined from kinetics of prothrombin activation as
described under Materials and Methods. Initial rates of
prothrombin activation were measured when a fixed amount
of factor Xa is titrated with factor Va and vice versa. True
initial rates were measured since linearity of prothrombin
activation was obtained at all factor Xa and factor Va con-
centrations used and the maximal amount of prothrombin
converted never exceeded 2Vo of the prothrombin added.
Factor Xa and factor Va were incubated for l0 min at 37 "C
in the presence of Ca2+ ions prior to addition of prothrombin,
since at the lowest factor Xa and factor Va concentrations
employed in our experiments, complex formation was reached
in 5 min.
The results of the titration experiments are shown in Figure
2A as a plot of the reciprocal value of the initial rate of
prothrombin activation vs. the reciprocal concentration of the
varied component (factor Va or factor Xa).3 The respective
dissociation constants and maximal rates of thrombin for-
mation are Ku= 3.5 x 104 M and Z* = 5.4 min-l for a fixed
amount of factor Xa and K6 = 3 .l x l0-e M and V*, = 5.1
min l for a fixed amount of factor Va. Since in both titrations
the amount of varied component was always in large excess
over the amount of fixed component, a negligible fraction of
the ligand is present in the complex, which justifies calculation
3 When a fixed amount of factor Va was titrated with factor Xa, a
correction was made for the contribution of noncomplexed factor Xa to
the rate of thrombin formation. At the factor Xa concentration required
to saturate SOVo f the factor Va present, the contribution of noncom-
plexed factor Xa to the rate of prothrombin activation was 6Vo of the total
activitv measured.
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Table I: Influence of Prothrombin and Prethrombin I on the K6
of the Factor Xa-Va Complex
, ' a
l ld
(nM)
prothrombin
substrate
concn
(rrM)
prethrombin 1
0.09
0.20
0.40
1.40
2.00
3.00
0.20
1.00
2.5
3 .7
4.9
3 .8
4.6
5.0
4.6
d The dissociation constants were calculated from double-
reciprocal plots obtained by titrating factor Xa with factor Va as
described in the legend to Figure 24.
of the dissociation constants from the concentration of added
ligand. The same Ka and 2."* values obtained in titrations
of factor Xa with factor Va and titrations of factor Va with
factor Xa show that in solution an equimolar complex is
formed between factor Xa and factor Va.
Effect of Ca2+ on Interaction between Factor Xa and Factor
Va in Solution. As shown by Rosing et al. (1980), the rate
of prothrombin activation by factor Xa in the presence of
factor Va increases to an optimum when the Ca2+ concen-
tration is increased from 0 to 3 mM. At higher Ca2+ con-
centrations the rate of prothrombin activation decreases again.
The data presented in Figure 3 confirm these findings. In this
figure the maximal rate of prothrombin activation is plotted
as a function of the Ca2+ concentration. Maximal rates of
prothrombin activation were calculated from double-reciprocal
plots obtained by titrating factor Xa with factor Va in the
presence of varying amounts of Ca2+ ions. The same Ca2+
dependence was found when prethrombin I or decarboxy-
prothrombin was used instead of prothrombin (data not
shown). Figure 3 also shows that the dissociation constant
of the factor Xa-Va complex is independent of the Ca2+
concentration between 0.5 and 30 mM. Since at Ca2+ con-
centrations below 0.5 mM rates of prothrombin activation were
too low to determine a K6,it could not be established whether
there is an absolute Ca2+ requirement for the interaction of
factor Xa with factor Va.
Effect of Prothrombin on Inleraction between Factor Xa
and Factor Va in Solution. Prothrombin interacts with factor
Va, presumably through the fragment 2 region of the pro-
thrombin molecule (Esmon et al., 1974). To examine whether
an interaction between prothrombin and factor Va affects the
formation of the factor Xa-Va complex in solution, we per-
formed titrations of factor Xa with factor Va at various pro-
thrombin concentrations. Factor Xa (0.32 nM) was titrated
with factor Va at prothrombin concentrations between 0.09
and 3.0 pM. The prothrombin concentrations are (far) below
the K. for prothrombin (Rosing et al., 1980). The fact that
the double-reciprocal plots of rates of prothrombin activation
vs. total factor Va added are linear at all prothrombin con-
centrations used indicates that initial rates of prothrombin
activation are also under these conditions a measure for the
amount of factor Xa-Va complex present.
The K6 values for the factor Xa-Va complex calculated from
these plots were independent of the amount of prothrombin
present (Table I). From these results we conclude that the
binding interaction between factor Xa and factor Va as in-
ferred from kinetics is not affected by an interaction of pro-
thrombin with factor Va and/or factor Xa.
Effect of 40Vo DOPS l60Vo DOPC Phospholipid Vesicles on
Interaction between Factor Xa and Factor Va. The binding
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FIGURE 2: Double-reciprocal p ots of binding interaction of factor Va with factor Xa. Factor Xa and factor Va were incubated for 10 min
at 37 oC either in the absence of phgqpholipid and 3 mM CaCl2 or in the presence of phospholipid and l0 mM CaCl2 in 1.0 mL of a buffer
containing-50 mM Tris-HCl, lQ.0 mM NaCl, and ovalbumin (0.5 mg/ml-), pH ?.5. The piothrombin activation was itarted by the addition
of l0 pJ-_of prolhroqbjq to give final concentrations as given below. After 2 and, 4 min,sampies were taken and assayed for thrombin as described
under Materials and Methods. Each point in_the double-reciprocal plot is the average of two independent measurements. Panel A gives the
9111!9.,T*."resconsistingof either 3.5 x l0-r0 M factor Xaand(l.i-12.0) x 104 M factor Va (of or 3.5 x l0r0 M factor va and (t:2-12.0)
f_!0-'M_factgr Xa (o). Final prothrombin concentration is 0.2 pM. Panel B gives the data'for mixtures consisting of either 2'.1 x ltri2
Y fg:tqt {ar.(0,t_S-Jrl)_I l0-'o_lul lactor Vq, 20 pM phospholipid (40VoDOPS/6OVI DOPC), and 10 mM CaCl2 (o) o'r 2.0 X l0-r2 M factorva' (O.15-1.5) x 10-'u M factorXa,20 pM phospholipid (407oDOPS/6OVIDOPC), and l0 mM CaCl2 (o). Final cdn6entration ofprothrombin
is !r_0 4{. _P3ne-t Q gives the data for mixtures consisting.of 2.1 x l}-t2 M factor Xa, (0.7-7.0) i i0-1r M factor Va, 5 pM fhospholipid(4OVo DOPSl607o DOPC), l0 mM CaCl2, and prothrombin concentrations of 0.05 pM (o) and 1.0 pM (a).
data obtained in the absence of phospholipid show that factor carried out with both factor Xa and factor Va as the limiting
Xa and factor Va form an equimolar complex with a disso- component. The respective apparent dissociation constants
ciation constant of 3.3 x l0-e M. Since both factor Xa and and maximal rates of prothtotnbin activation are K6 = J.J ;
factor Va bind with a high affinity to negatively charged l0-rr M andvmax= l230min-r forafixedamountof factor
phospholipid vesicles (Nelsestuen & Broderius, 1977; Bloom Xa and Ka= 4.6 x 10-rr M and Z* = 1050 min r for a fixed
et al., 1979), it is likely that the presence of phospholipid amount of factor Va.4 Also in theie experiments, the amount
affects in some manner the dissociation constant of the factor of ligand added was always in large eic"rs ouer the amount
Xa-Va complex. From the fact that much lower amounts of of limiting component. Therefore, it was justified to express
factor Va were required to optimize prothrombin activation the apparent K6 in terms of total added iigand. Under the
in the presence of phospholipid than in solution, Rosing et al. same conditions but in the absence of phospholipid, the rate
(1980) suggested that phospholipid promotes the formation of thrombin formation is negligible ur-"ornpu."d to the rate
of the factor Xa-Va complex. Also, the kinetic studies of of thrombin formation in thi presen"" of phospholipid.
Nesheim et al. (1979b, l98l) and the binding studies of Tracy Therefore, the prothrombin activation -"uru."d is restricted
et al. (1981) indicate that factor Xa has an increased affinity to reactions taking place at the phospholipid surface and the
toward phospholipid-bound factor Va. result of interactions between factor Xa and factor Va at that
To appreciate the assembling function of phospholipid in
the formation of the factor Xa-Va complex, we determined
apparent dissociation constants at different phospholipid
concentrations by the kinetic method as described under
Materials and Methods. Figure 28 shows the result of a
typical experiment carried out in the presence of 20 pM
phospholipid (40Vo DOPS16070 DOPC). Titrations were
a When a fixed amount of factor Va was titrated with factor Xa, a
correction was made for the contribution of noncomplexed factor Xa to
the rate of thrombin formation. At the factor Xa concentration required
to saturate 50Vo of the factor Va present, the contribution of noncom-
plexed factor Xa to the rate of prothrombin activation was 87o of the total
activity measured.
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Table II: Effect of Phospholipid Vesicles (40% DOPS/60%DOPC)
on the Apparent Dissociation Constant of the Factor Xa-Va
Complex
phospholipid prothrombin
concn concn
GrM) 0rM)
v  o L .  2  1  .  N O  .  2 2 ,  r s 8 2  5 4 9 9
Table III: Dissociation Constant Determined by Kinetics for
Interaction of Factor Xa with Factor Va in the Presence of
Phospholipid Vesicleso of Varying Phosphatidylserine (PS)
Content
fraction total lipid
PS concn
(7o) 0..M)
prothrombin
concn
(pM) V^oorab (ttt)
10
15
20
30
40
10
20
50
100
150
10
10
10
10
10
33 x  10-1r
25 x 10-"
2g  x  10- r '
2g  x  L0-11
2g x  10-1r
9 .0  x  10- r1
3 .8  x  10- r r
2 .9  x  10- r '
3 .0  x  10-1 t
3 .0  x  10- r l
0.2
1 .0
2.0
2.0
0.2
0.2
0.2
0.2
0.2
1040
950
1200
1200
1200
1300
1,440
t490
1400
1 350
a The apparent dissociation constants and V^ * were calculated
from double-reciprocal plots obtained by titrating factor Xa with
factor Va as described in the legend to Figure 28. o The rates are
expressed in moles of factor IIa per mjnute per mole of factor Xa.
surface. The data obtained in Figure 28 show that a phos-
pholipid surface promotes the formation of the factor Xa-Va
complex by decreasing the dissociation constant about 100-fold.
Binding parameters obtained from double-reciprocal plots
of titrations of a fixed amount of factor Xa with factor Va
in the presence ofvarying amounts ofphospholipid are listed
in Table II. The apparent dissociation constant increases when
the phospholipid concentration is raised' At phospholipid
concentrations higher than25 pM the increase ofthe disso-
ciation constant is linear with the amount of phospholipid
present.
Since the K- for prothrombin varies with the phospholipid
concentration (Rosing et al., 1980), the experiments presented
in Table II were performed at variable amounts of pro-
thrombin. The prothrombin concentrations employed were
at least 4 times higher than the apparent K- for prothrombin
in order to approach the true Z-"" ofprothrombin activation
as close as possible. As shown in Table II, the 2."* values
4 Phosoholipid vesicles were made as described under Materials
and Methotls.- b Th" Ku and V^* were calculated from double-
reciprocal plots obtained by titrating factor Xa (2.0 X 10-1'? M)
with factor Va as described in the legend to Figure 28. The rates
are expressed in moles of factor IIa per minute per mole of factor
Xa.
at different phospholipid concentrations are abut equal. From
this and the assumption that all factor Xa is saturated with
substrate, we conclude that all factor Xa present in the reaction
mixtures participates in a membrane-bound factor Xa-Va
complex.
It can be argued that prothrombin might interfere with the
formation of the factor Xa-Va complex at the phospholipid
surface either by interaction with factor Xa and/or factor Va
or by competition with factor Xa and/or factor Va for binding
sites at the phospholipid surface. Since a 20-fold variation
of the prothrombin concentration did not affect the apparent
dissociation constant (Figure 2C), we conclude that pro-
thrombin does not interfere with the assembly of the factor
Xa-Va complex at the phospholipid surface. The increase of
the V^ * from 670 to 1000 mol of thrombin min-l (mol of
factor Xa)-l presumably reflects substrate saturation ofpro-
thrombin activation, since the apparent K- for prothrombin
in the presence of 5 pM phospholipid is 0.06 pM. A phos-
pholipid concentration of 5 irM was chosen for this experiment
iincJit provides a limited number of binding sites for factor
Xa and factor Va, which would have made competition, if
occurring, more easily detectable'
Interaction between Factor Xa and Factor Va at Phos-
pholipid Vesicles with Varying Phosphatidylserine Content'
It has been demonstrated that binding of both factor Xa and
factor Va to membranes requires the presence of negatively
charged phospholipids (Bloom et al., 1979; Nelsestuen &
Broderius, 1977). Nelsestuen & Broderius (1977) found that
below 20Vo phosphatidylserine the factor Xa binding capacity
was directly proportional to the phosphatidylserine content.
The data of Bloom et al. (1979) suggest that below 25Vo
phosphatidylserine the binding capacity of factor Va is also
directly proportional to the phosphatidylserine content' The
characteristics of the formation of the factor Xa-Va complex
at membranes containing varying amounts of phosphatidyl-
serine are shown in Table III. The results show that the
Ka(app) of the factor Xa-Va complex decreases up to about
20Vo phosphatidylserine and is then constant to 50% phos-
phatidylserine. The maximal rate of prothrombin activation
did not change with the phosphatidylserine content'
Table III also shows that at high phosphatidylserine content
(40Vo) the Ko of the factor Xa-Va complex increases pro-
portional to the phospholipid concentration. At low phos-
phatidylserine content (5Vo) the Ka(app) is independent ofthe
3 02 0l 0
nrcune 3: Effect of Ca2+ concentration on the V^ ' of thrombin
formation and the dissociation constant of the factor Xa-Va complex.
Factor Xa (3.5 x l0-r0 M) was titrated with factor Va in the presence
of varying amounts of Ca2+ as described in the legend to Figure 2A.
The i6nic strength of the reaction mixtures was kept constant.by
varying the Nael concentration. The maximal rates of prothrombin
activation (V,vefiical axis, lower panel) and the dissociation constant
(K6, vertical axis, upper panel) were determined from double-reciprocal
plols of rate of thrombin formation vs. added factor Va.
Ka(app)"
(M) , r b7 r o x
1 .0
1 .0
1 .0
1.0
1.0
1.0
2.0
3.0
6.0
z
5
1 0
25
50
100
125
150
300
1.39  x  10- r r
2 .30  x  10- ! r
2 .84  x  10- r r
4 .51  X 10- r '
9 .29  x  10- r1
15.80  x  10- r1
18.90  x  10- r r
27.00 x 10-rr
52 .20  x  10- r r
I  190
1000
1280
1600
1380
1 100
1590
15 80
1780
5 5 0 0  B r o c H E M r s r R Y
Table IV: Effect of Factor V Activation Fragments on the
Binding Interaction between Factor Va and Factor Xao
added component
factor factor
Xa Va
(nM) (nM)
0.35 1.0-10.0
0,35 none
0.35 1.0-10.0
0.35 Lr10.0
concn Kd h
fragments (nM) (nM) I/max"
L I N D H O U T  E T  A L .
teraction between the polypeptides with M, 80000 and 94000
of which factor Va is composed.
Discussion
The interaction between factor Xa and factor Va in the
presence of phosphatidylserine-phosphatidylcholine vesicles
and platelets has been studied in several aboratories (Nesheim
et al., 1979b; Kane et al., 1980; Tracy et al., l98l). The results
obtained suggest a coordinate binding of factor Xa and factor
Va to phospholipid and platelets and the formation of a
stoichiometric (l:1) complex. The dissociation constant for
factor Xa dissociation from the phospholipid-bound complex
(& - tO-to M) is several orders of magnitude less than the
dissociation constant for factor Xa-phospholipid interaction
(& - 10-{ M) (Nelsestuen & Broderius, 1977; Bloom et al.,
1979). On the basis of these observations, it has been pos-
tulated that binding of factor Va to phospholipid increases the
binding affinity for factor Xa. Therefore, relatively high
concentrations of factor Xa are obtained in the vicinity of
phospholipid vesicles and platelets when factor Va is present
(Nesheim et al., l98l). There exists, however, no insight in
the interactions responsible for the increased affinity of factor
Xa for phospholipid-bound factor Va. The question is to what
extent factor Xa-phospholipid, factor Va-phospholipid, and
protein-protein interactions contribute to the increased affinity
of phospholipid-bound factor Va for factor Xa.
The studies presented in this paper were initiated in order
to disclose the contribution of both proteingotein and pro-
tein-phospholipid interactions to the high affinity of the
phospholipid-bound factor Va for factor Xa. The method used
to study the interaction between factor Xa and factor Va is
based on the assumption that a factor Xa-Va complex is the
functional enzyme in prothrombin activation (Nesheim et al.,
1979b; Rosing et al., 1980) and that the rates of prothrombin
activation by factor Xa in the presence of factor Va are pro-
portional to the amount of factor Xa-Va complex in the re-
action mixture. In the absence of phospholipid, titrations of
a fixed amount of factor Xa with factor Va or vice versa yield
at saturation the same maximal rates for prothrombin acti-
vation per mole of fixed component (Figure 2A). The same
observation was made in titration experiments in the presence
of phospholipid (Figure 28). Since factor Va is a nonenzy-
matic component, these results indicate that in both the ab-
sence and presence of phospholipid, the catalytic unit in the
prothrombin activation is a stoichiometric (1:l) complex of
factor Xa and factor Va.
Because prothrombin has the ability to interact with factor
Va through the fragment 2 region of the prothrombin molecule
(Esmon et al., 197 4) and factor Va amplifies the turnover of
prothrombin by factor Xa by not yet disclosed means (Rosing
et al., 1980), the question arises whether prothrombin interferes
with the interaction between factor Xa and factor Va. Given
the following observations, it seems unlikely that prothrombin
participates in the formation of the factor Xa-Va complex:
(l) The dissociation constant of the factor Xa-Va complex
is independent of the prothrombin concentration when the
molar ratios of prothrombin to factor Va were varied from 9
to 3000 (Table I), (2) in the presence of phospholipid, the
apparent dissociation constant was also independent on the
prothrombin concentration (Figure 2C), and (3) Nesheim et
al. (1981) showed that the binding parameters of the inter-
action between factor Xa and phospholipid-bound factor Va
inferred from alterations in the rate of hydrolysis of S 2222
are similar to those obtained with prothrombin as a substrate.
Rosing et al. (1980) demonstrated that the generation of
thrombin, upon incubation of prothrombin with factor Xa and
4.0 4.'1
3.5 4.3
I
2
J
4
none
restored 1.0-10.0
factor Va
factor Va 50
LC
factor Va 100
HC
3.7 5.0
3.3 4.5
o Ther(4 and V^* values were determined from double-
reciprocal plots of rates of thrombin formation vs. added factor
Va or restored factor Va- Further expgrimental details are
descdbed in the legend to Figure 2A. D The rates axe expressed
in moles of factor IIa per minute per mole of factor Xa
phospholipid concentrations, ranging from 50 to 150 pM. It
is apparent that almost all factor Xa added binds to the
phospholipid surface and can be saturated with factor Va, since
maximal rates of thrombin formation were found to be inde-
pendent of the phospholipid concentration and slightly less than
those observed for vesicles with a high phosphatidylserine
content.
Studies on Interaction of Factor Ya Subunits with Factor
Xa. ln our studies we have used an unfractionated factor Va
preparation that contains the biologically active factor Va,
composed of two polypeptide chains with M,80 000 (factor
Va LC) and 94 000 (factor Va HC) and activation peptides
with M, I 50 000 and 65 000. It is of interest to investigate
whether the presence of those activation peptides affects the
interaction between factor Va and factor Xa and to examine
whether restoration of biological activity correlates with the
Ca2+-mediated complex formation between factor Va LC and
factor Va HC, showing the same binding characteristics to-
ward factor Xa as does the "native" factor Va. Titration of
factor Xa (0.5 x l0-e M) with restored factor Va [(1.0-10)
x 104 Ml was performed as described in the legend to Figure
2A. The K6 and Z.u, values calculated from a double-recip-
rocal plot of the rate of prothrombin activation vs. added factor
Va HC-factor Va LC complex are presented in Table IV. A
comparison between entries I and 2 indicates that (a) the
activation peptides have no effect on the interaction between
factor Xa and factor Va and (b) the binding characteristics
of restored factor Va are the same as those of native factor
Va. These findings strongly support the observations made
by Esmon (1979) that two nonidentical peptides derived from
the procofactor are required for biological function. These
observations also suggest that the two'chain structure of factor
Va is required for binding factor Xa andf or prothrombin.
Whether the interaction between factor Xa and one of the
peptides is impaired because of the absence of the other peptide
can easily be demonstrated. If one of the peptides forms a
complex with factor Xa, this peptide is likely to be inhibitory,
since it will competitively removes factor Xa from interaction
with factor Va, thereby reducing the concentration of the
functional enzyme (factor Xa-Va complex) in prothrombin
activation. Table IV, entries 3 and 4, clearly demonstrates
that in the presence of a large molar excess of factor Va LC
or factor Va HC over factor Va, the dissociation constants and
I/."" values are similar to those found in the absence of each
of the chains. It is apparent that neither factor Va HC nor
factor Va LC is able to compete with factor Va in a complex
formation with factor Xa. From these data we conclude that
factor Xa binding to factor Va requires a Ca2+-mediated in-
F A C T O R  X A _ F A C T O R  V A  I N T E R A C T I O N
Table V: Apparent Dissociation Constant for Interaction of
Factor Xa with Factor Va and Corresponding Factor Va
Concentration on the Phospholipid Surface and Factor Va
Concentration in Solution at Varying Phospholipid Concentrations
and Phosphatidylserine Content of DOPC/DOPS Vesicles
factor Va
concn on
[factor phospho-
Va]ft"" lipid
X 10rr surface
(M) (pmofmol)
v o L .  2 1  .  N O  .  2 2 .  1 s 8 2  5 5 0 1
tants is direct in the three-dimensional sense. The increased
affinity would result from additive effects of protein-phos-
pholipid and proteinlrotein interactions (Nelsestuen, 1978).
Thus, the formation of the factor Xa-Va complex will de-
pend on the factor Va concentration on the phospholipid
surface (model l) or on the concentration of factor Va in the
bulk solution (model 2). If one is given the published binding
parameters (Bloom et al., 1979) and the amount of factor Va
added required to achieve half-saturation of phospholipid-
bound factor Xa (apparent K6 value), the concentration of
phospholipid-bound factor Va and the concentration of factor
Va in bulk solution can be calculated (Table V). The de-
pendency of the apparent K6 of the phospholipid concentration
and phosphatidylserine content of the vesicle can be ration-
alized quantitatively in the context of both models.
Model 1. The affinity of factor Va for vesicles increases
up to about 20% phosphatidylserine. In order to obtain a factor
Va concentration of l-2 pmol of factor Va/mol of phospholipid
at the phospholipid surface required to achieve hall'-saturation
of phospholipid-bound factor Xa, it is necessary to add less
factor Va with increasing phosphatidylserine content. In-
creased affinity also implies that the phospholipid concentration
might become inhibitory. The amount of added factor Va has
to increase with the increase in phospholipid concentration to
attain l-2 pmol of factor Va/mol of phospholipid at the
surface.
Model 2. An increase in phospholipid concentration will
competitively remove factor Va from interaction with the
factor Xa-phospholipid site, depending on the affrnity of factor
Va for the phospholipid surface. Consequently, the amount
of added factor Va has to increase with increase in phospho-
lipid concentration to attain a factor Va concentration in the
bulk solution to achieve half-saturation of phospholipid-bound
factor Xa.
The combined results of this study support the notion that
the enzymatic component of the prothrombin converting
complex consists of an equimolar phospholipid-bound complex
of factor Xa and factor Va. In addition, the "quality" of the
phospholipid surface (phosphatidylserine content) upon which
the factor Xa-Va complex is formed can act as a regulator
of the catalytic activity of the prothrombinase complex.
Therefore, our data have to be taken into consideration in a
discussion about the physiological significance of negatively
charged phospholipids exposed on the outer surface of
thrombin/collagen-activated platelets (Bevers et al., I 982).
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